Losers Watch List: Maxwell Technologies, FreeSeas Inc. (NASDAQ:FREE), Chesapeake Granite Wash, CARDIOME PHARMA CORP (NASDAQ:CRME)

Lakeway, NY -- (SBWIRE) -- 03/21/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Maxwell Technologies Inc.(NASDAQ:MXWL) shares declined 20.56% to $5.91. Morgan & Morgan on Mar. 20 announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of Maxwell Technologies, Inc. ("Maxwell Technologies" or the "Company") (Nasdaq:MXWL) common stock during the period between April 28, 2011 and March 7, 2013 inclusive (the "Class Period").

How Should Investors Trade MXWL After The Recent Price movement? Find out Here

FreeSeas Inc. (NASDAQ:FREE) shares dropped 19.73% to $1.18. The company, on Feb. 14, announced that the Company's Amended and Restated Articles of Incorporation were amended to effect a reverse stock split of the Company's issued and outstanding common stock at a ratio of one new share for every 10 shares currently outstanding.

Is FREE a Strong Buying Opportunity After The Recent Slump? Find out Here

Chesapeake Granite Wash Trust(NYSE:CHKR) shares fell 15.27% to $14.37. The company, on Mar. 15, delivered notice to the Depositary to redeem the company's 6.775% Senior Notes due 2019 (the "Notes") at par. In addition, Chesapeake is continuing to pursue its lawsuit requesting the United States District Court for the Southern District of New York confirm that the notice to redeem the Notes the company issued today will be timely and effective to redeem the Notes at par, with payment to be made within 60 days after such notice, pursuant to the Special Early redemption provision of the Notes.

Is CHKR a Buy After The Latest Price Action? Find Out Here

CARDIOME PHARMA CORP (NASDAQ:CRME) shares decreased 8.24% and closed at $0.324. The company, on Mar. 15, reported that net income for the fourth quarter of 2012 was $7.7 million or $0.13 income per share, compared to a net loss of $5.9 million or $0.10 loss per share for the fourth quarter of 2011. Total revenue for the quarter were $0.1 million down from $0.4 million last year. Analysts expected the company to report a loss of $0.05 per share on revenues of $840 thousand for the quarter.

Is CRME a Strong Buying Opportunity After The Recent Slump? Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.